Kim HooKim

733 total citations
23 papers, 422 citations indexed

About

Kim HooKim is a scholar working on Oncology, Surgery and Epidemiology. According to data from OpenAlex, Kim HooKim has authored 23 papers receiving a total of 422 indexed citations (citations by other indexed papers that have themselves been cited), including 12 papers in Oncology, 8 papers in Surgery and 6 papers in Epidemiology. Recurrent topics in Kim HooKim's work include Neuroendocrine Tumor Research Advances (4 papers), Pancreatitis Pathology and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kim HooKim is often cited by papers focused on Neuroendocrine Tumor Research Advances (4 papers), Pancreatitis Pathology and Treatment (3 papers) and Pancreatic and Hepatic Oncology Research (3 papers). Kim HooKim collaborates with scholars based in United States, Switzerland and Canada. Kim HooKim's co-authors include Michelle D. Reid, Mark Edgar, Harold C. Sullivan, C. M. S. Cohen, Michael H. Roh, Stewart M. Knoepp, Kristina Fields, Timothy J. Purwin, Inna Chervoneva and Oscar Lin and has published in prestigious journals such as Journal of Clinical Pathology, Cancer Discovery and Cell Death and Disease.

In The Last Decade

Kim HooKim

22 papers receiving 419 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Kim HooKim United States 11 246 155 107 97 69 23 422
Raffaele Solla Italy 12 160 0.7× 119 0.8× 95 0.9× 48 0.5× 60 0.9× 24 480
I Weng Lao China 15 191 0.8× 294 1.9× 59 0.6× 123 1.3× 72 1.0× 34 597
Alessandra Alessi Italy 14 206 0.8× 122 0.8× 153 1.4× 93 1.0× 30 0.4× 39 572
Fang Fan United States 12 264 1.1× 99 0.6× 132 1.2× 57 0.6× 50 0.7× 36 469
Byoung Hyuck Kim South Korea 15 228 0.9× 198 1.3× 206 1.9× 83 0.9× 18 0.3× 70 564
Qiugen Hu China 11 204 0.8× 136 0.9× 63 0.6× 37 0.4× 26 0.4× 35 477
Francesca Pagliuca Italy 12 132 0.5× 67 0.4× 112 1.0× 64 0.7× 17 0.2× 42 357
Kota Washimi Japan 12 99 0.4× 163 1.1× 86 0.8× 40 0.4× 18 0.3× 52 353
Keiichi Kinowaki Japan 11 141 0.6× 97 0.6× 72 0.7× 142 1.5× 15 0.2× 99 479

Countries citing papers authored by Kim HooKim

Since Specialization
Citations

This map shows the geographic impact of Kim HooKim's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Kim HooKim with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Kim HooKim more than expected).

Fields of papers citing papers by Kim HooKim

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Kim HooKim. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Kim HooKim. The network helps show where Kim HooKim may publish in the future.

Co-authorship network of co-authors of Kim HooKim

This figure shows the co-authorship network connecting the top 25 collaborators of Kim HooKim. A scholar is included among the top collaborators of Kim HooKim based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Kim HooKim. Kim HooKim is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Büchner, S.A., et al.. (2024). An Unusual Presentation of Cutaneous Bullous Lupus. Cureus. 16(11). e74140–e74140.
2.
HooKim, Kim, et al.. (2024). Kaposi sarcoma in an individual recently diagnosed with HIV. IDCases. 36. e01961–e01961. 1 indexed citations
3.
Goetz, Austin, Avinoam Nevler, Gabi Barmettler, et al.. (2021). Accuracy of cytopathology evaluation for resected benign and malignant pancreatic disease. Journal of Surgical Oncology. 124(3). 343–353. 1 indexed citations
4.
Sebastiano, Christopher, et al.. (2020). Cytological interpretation of p16 immunohistochemistry in head and neck carcinomas: does the choice of fixative matter?. Journal of the American Society of Cytopathology. 10(2). 216–224. 14 indexed citations
5.
HooKim, Kim, Alexander Sevrukov, Theodore N. Tsangaris, et al.. (2020). Is radial scar on core needle biopsy a risk factor for malignancy? A single‐center retrospective review and implications for management. The Breast Journal. 26(10). 2011–2014. 5 indexed citations
6.
Calio, Brian, Sandeep Deshmukh, Donald G. Mitchell, et al.. (2019). Spatial distribution of biopsy cores and the detection of intra-lesion pathologic heterogeneity. Therapeutic Advances in Urology. 11. 2078064053–2078064053. 8 indexed citations
7.
Hartsough, Edward J., Michele B. Weiss, Timothy J. Purwin, et al.. (2019). CADM1 is a TWIST1-regulated suppressor of invasion and survival. Cell Death and Disease. 10(4). 281–281. 36 indexed citations
8.
HooKim, Kim, et al.. (2019). Castleman Disease: An Uncommon Mass in the Retroperitoneum. Urology. 136. e12–e15. 1 indexed citations
9.
Bhattarai, Shristi, Rondell P. Graham, Carlie Sigel, et al.. (2019). Bile duct involvement by hepatocellular carcinoma: A rare occurrence and poor prognostic indicator in bile duct brushing samples. Cancer Cytopathology. 127(11). 691–699. 5 indexed citations
10.
Teh, Jessica L.F., Phil F. Cheng, Timothy J. Purwin, et al.. (2018). In Vivo E2F Reporting Reveals Efficacious Schedules of MEK1/2–CDK4/6 Targeting and mTOR–S6 Resistance Mechanisms. Cancer Discovery. 8(5). 568–581. 61 indexed citations
11.
Reid, Michelle D., Takashi Muraki, Kim HooKim, et al.. (2017). Cytologic features and clinical implications of undifferentiated carcinoma with osteoclastic giant cells of the pancreas: An analysis of 15 cases. Cancer Cytopathology. 125(7). 563–575. 43 indexed citations
12.
Geller, Rachel, et al.. (2016). Cytologic features of angiosarcoma: A review of 26 cases diagnosed on FNA. Cancer Cytopathology. 124(9). 659–668. 36 indexed citations
14.
HooKim, Kim, et al.. (2015). Secondary tumors involving the thyroid gland: A multi‐institutional analysis of 28 cases diagnosed on fine‐needle aspiration. Diagnostic Cytopathology. 43(11). 904–911. 27 indexed citations
15.
Sullivan, Harold C., et al.. (2014). The utility of ERG, CD31 and CD34 in the cytological diagnosis of angiosarcoma: an analysis of 25 cases. Journal of Clinical Pathology. 68(1). 44–50. 68 indexed citations
16.
HooKim, Kim, et al.. (2014). “Equivocal” High-Risk HPV DNA Tests Performed on ThinPrep Specimens After ASC-US Diagnoses Are Associated With an Increased Incidence of CIN3. Journal of Lower Genital Tract Disease. 18(4). 291–297. 1 indexed citations
17.
HooKim, Kim, et al.. (2013). Napsin A expression in small cell carcinoma of the lung: a cytologic study with review of differentials. Journal of the American Society of Cytopathology. 3(2). 90–95. 1 indexed citations
18.
HooKim, Kim, Michael H. Roh, Joseph H. Willman, et al.. (2011). Application of immunocytochemistry and BRAF mutational analysis to direct smears of metastatic melanoma. Cancer Cytopathology. 120(1). 52–61. 36 indexed citations
19.
Jing, Xin, Stewart M. Knoepp, Michael H. Roh, et al.. (2011). Group consensus review minimizes the diagnosis of “follicular lesion of undetermined significance” and improves cytohistologic concordance. Diagnostic Cytopathology. 40(12). 1037–1042. 33 indexed citations
20.
Knoepp, Stewart M., et al.. (2011). The application of immunocytochemistry to cytologic direct smears of metastatic merkel cell carcinoma. Diagnostic Cytopathology. 41(8). 729–733. 20 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026